Former Green Bay, New England, and Cleveland football player Joe Andruzzi has just completed the first of a 12-step series of chemotherapy treatments for Burkitt's lymphoma, a form of non-Hodgkins lymphoma.
Andruzzi, married and dad to four children, was released by the Browns on May 2 so he and his family could move to New Jersey. Then last week, Andruzzi began experiencing abdominal pain and other symptoms. He consulted with the Browns' medical staff, underwent a colonoscopy, learned an abnormality was found, and then headed to Dana-Farber Cancer Institute in Boston where he was diagnosed with Burkitt's.
The cure rate for Burkitt's -- a rapidly growing, rare form of cancer that strikes only 100 people in the United States each year -- is about 80 percent if patients receive intensive therapy, according to the National Cancer Institute. The other patient survival factor is the stage of the disease. Andruzzi's stage has not been publicly reported.
If we made no further progress in breast cancer research from this day on, the number of women dying from breast cancer five years from now would still drop substantially because we've progressed so much over the past few years, says MD Eric Winer in the October 2006 issue of Oprah magazine. Winer, director of the Breast Oncology Center at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School, is right. There has been a lot of progress. Breast cancer research is on a roll. And here are seven reasons why.
